Johnson & Johnson earnings per share (EPS) for the twelve months ending Feb 03, 2025 was $6.1, a (56.3%) increase year-over-year.
As of Feb 03, 2025, Johnson & Johnson's P/E ratio is 24.9x. This is calculated by dividing the current share price of $151.9 by the Earnings per Share (EPS) for the trailing twelve months, which is $6.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $193.7, compared to a market price of around $151.9. This suggests a potential undervaluation of 27.5%.